tiprankstipranks
Trending News
More News >
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market

PharmaCyte Biotech (PMCB) Income Statement

Compare
253 Followers

PharmaCyte Biotech Income Statement

Last quarter (Q1 2026), PharmaCyte Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, PharmaCyte Biotech's net income was $-8.36M. See PharmaCyte Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.38M$ 6.52M$ 6.46M$ 4.39M$ 3.62M
Depreciation and Amortization
$ 0.00$ 6.52M$ 6.46M$ 0.00$ 0.00
EBITDA
$ 30.66M$ 6.85M$ -4.32M$ -4.24M$ -3.55M
Operating Income
$ -4.38M$ -6.52M$ -6.46M$ -4.39M$ -3.62M
Other Income/Expenses
$ 35.03M$ 6.85M$ 2.14M$ 152.85K$ 71.75K
Pretax Income
$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Net Income
$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Per Share Metrics
Basic EPS
$ 3.19$ -1.80$ -0.22$ -0.27$ -2.46
Diluted EPS
$ 3.19$ -1.80$ -0.83$ -0.79$ -2.46
Weighted Average Shares Outstanding
7.33M 9.58M 19.49M 15.52M 1.45M
Weighted Average Shares Outstanding (Diluted)
7.33M 9.58M 5.18M 5.18M 1.45M
Currency in USD

PharmaCyte Biotech Earnings and Revenue History